Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2001
11/01/2001WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001WO2001081377A2 Integrin/adhesion antagonists
11/01/2001WO2001081363A1 Novel compounds
11/01/2001WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
11/01/2001WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme
11/01/2001WO2001081333A2 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
11/01/2001WO2001081332A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
11/01/2001WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/01/2001WO2001081314A1 Naphthamidine urokinase inhibitors
11/01/2001WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
11/01/2001WO2001081310A1 1-aroyl-piperidinyl benzamidines
11/01/2001WO2001080894A2 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
11/01/2001WO2001080876A1 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator
11/01/2001WO2001080875A1 A memory enhancing protein
11/01/2001WO2001080865A2 Joint repair using mesenchymal stem cells
11/01/2001WO2001080856A2 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
11/01/2001WO2001080841A2 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
11/01/2001WO2001080810A2 Chondroitin synthase gene and methods of making and using same
11/01/2001WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base
11/01/2001WO2001041762A3 Valdecoxib compositions
11/01/2001WO2001041761A3 Valdecoxib compositions
11/01/2001WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001WO2001036604A3 Nucleic acids encoding endotheliases, endotheliases and uses thereof
11/01/2001WO2001034640A3 Peptide (virip) which inhibits a circulating virus in humans and the use thereof
11/01/2001WO2001032866A3 Hybrid adaptor receptors
11/01/2001WO2001029189A3 Synthetic substrate for tissue formation
11/01/2001WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001WO2001012233A3 Sustained release formulation of a peptide
11/01/2001WO2001010847A3 Novel integrin receptor antagonists
11/01/2001US20010036956 Estrogen receptor modulators
11/01/2001US20010036946 Antiinflammatory agents
11/01/2001US20010036937 Intensive care unit
11/01/2001US20010036936 Compositions and methods for treating osteoporosis
11/01/2001US20010036921 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/01/2001US20010036475 Pharmaceutical tablets
11/01/2001US20010036454 Transfection of lung tissue
11/01/2001CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001CA2407449A1 Novel compounds
11/01/2001CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b|-pyridines as cyclin dependent kinase inhibitors
11/01/2001CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001CA2407086A1 Integrin/adhesion antagonists
11/01/2001CA2407021A1 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
11/01/2001CA2406998A1 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
11/01/2001CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2406073A1 A protein kinase c variant to alter memory
11/01/2001CA2405543A1 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
10/2001
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149583A2 Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
10/31/2001EP1149116A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/31/2001EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001EP1149092A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
10/31/2001EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1149057A1 Biodegradable glass compositions and methods for radiation therapy
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148897A1 Methods and compositions for healing and repair of articular cartilage
10/31/2001EP1148877A1 Methods for inhibiting bone resorption
10/31/2001EP1148876A1 Calcilytic compounds
10/31/2001EP0901466B1 Biphenylsulfonamide matrix metalloproteinase inhibitors
10/31/2001EP0888292B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY ALPHAvBETA3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001CN1319425A Medical preparation for stasis-eliminating and soothing sinew
10/31/2001CN1319421A Oral liquid for treating numbness pain
10/31/2001CN1319414A Medicine for treating hecrosis of femoral head
10/31/2001CN1319408A Medicated liquor for treating traumatic injury
10/31/2001CN1319396A Medicinal composition
10/30/2001US6310226 Vitamin D analogues
10/30/2001US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001US6310099 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
10/30/2001US6310084 Inhibitors of metalloproteases involved in tissue degradation
10/30/2001US6310079 Non-steroidal antiinflammatory agents
10/30/2001US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/30/2001US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001CA2052375C Parathyroid hormone derivatives
10/25/2001WO2001083485A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079479A2 Methods for selective targeting
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079298A1 Novel recombinant antibodies, amino acid sequences of cdrs thereof and genes encoding the same
10/25/2001WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001WO2001079284A2 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001WO2001079206A1 Tricyclic quinazolinediones
10/25/2001WO2001079197A1 ACTIVATORS FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ (PPARδ)
10/25/2001WO2001079184A1 Substituted piperazine compounds
10/25/2001WO2001079173A2 Enamine derivatives as cell adhesion molecules
10/25/2001WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
1 ... 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 ... 820